{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Return to msk.org
Memorial Sloan Kettering Cancer Center
  • Sign In
  • Live Courses
  • On Demand eLearning
  • Coming Soon
  • Visiting Us
  • About
  • Resources & Policies
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

Select a button below to sign in or create an account. If you have previously registered or attended a MSK CME event, please sign in using the username and password created at course registration. MSK employees must use their SSO credentials to sign in. 

Single Sign On (MSK Employees)
Sign in or Create an Account
Enter your email and password to login:

*
*
Login

New to Memorial Sloan Kettering Cancer Center? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • ACHPN
  • ACNP
  • ACNP-BC
  • AGACNP
  • AGACNP-BC
  • AGCNS
  • AGNP
  • AGNP-BC
  • ANP
  • ANP-BC
  • AS
  • AT
  • AuD
  • BA
  • BAO
  • BCC
  • BCh
  • Bchir
  • BM
  • BS
  • BS, MS
  • BSN
  • BSN, MS
  • BSN, MS, DNP
  • CCC-SLP
  • CCLS
  • CCRN
  • CCRP
  • CEN
  • ChB
  • CIPS
  • CNM
  • CNP
  • CPNP
  • CPNP-AC
  • CRNA
  • CRNP
  • CTTS
  • D(ABMM)
  • DAc
  • DACM
  • DAHM
  • DAOM
  • DDS
  • DDS, MPH
  • DMD
  • DMD, PhD
  • DNB
  • DNP
  • DNP, RN
  • DNSc
  • DO
  • DPM
  • DPM
  • DPT
  • DrPH
  • DSc
  • DVM
  • EdD
  • EdS
  • FAAP
  • FACNM
  • FACOG
  • FACS
  • FASCRS
  • FASN
  • FCCM
  • FCCP
  • FIPP
  • FNP
  • FNP-BC
  • GNP
  • GNP-BC
  • HUC
  • JD
  • LAc
  • LCSW
  • LISW
  • LISW-S
  • LMSW
  • LPCC
  • LPN
  • LSW
  • MA
  • MAc
  • MAcOM
  • MB
  • MB, PhD
  • MBA
  • MBBCh
  • MBBCh BAO
  • MBBCh BAO, PhD
  • MBBCh, MPH
  • MBBCh, PhD
  • MBBS
  • MBBS, MPH
  • MBBS, PhD
  • MBChB
  • MD
  • MD, DSc
  • MD, FCCP
  • MD, FCCP, DAABIP
  • MD, JD
  • MD, MA
  • MD, MAS
  • MD, MBA
  • MD, MHA
  • MD, MPH
  • MD, MPH, MHS
  • MD, MS
  • MD, MS, PhD
  • MD, PhD
  • MD, PhD, MA
  • MD, PhD, MPH
  • MD, PhD, MS
  • MDiv
  • MDS
  • MEd
  • MHS
  • MPA
  • MPH
  • MPhil
  • MS
  • MSc
  • MSc, PhD
  • MSN
  • MSPH
  • NCTTP
  • None
  • NP
  • NP, RN
  • OCN
  • OD
  • Other
  • OTR
  • PA
  • PA-C
  • PCA
  • PharmD
  • PharmD, PhD
  • PhD
  • PhD, MBA, MS
  • PhD, MPH
  • PhD, MPhil
  • PhD, MS
  • PhD, MSc
  • PhD, NP, RN
  • PsyD
  • PT
  • RA
  • RCS
  • RD
  • RDCS
  • RDMS
  • RN
  • RN-BC
  • RPh
  • RRT
  • RT
  • ScD
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

2025 Accelerated Review in Medical Oncology


2025 Accelerated Review in Medical Oncology Banner

  • Overview
  • Register
  • Brochure
  • Faculty
  • Accommodations
Add to Calendar 2025 Accelerated Review in Medical Oncology 10/31/2025 7:45:00 AM 11/1/2025 6:15:00 PM America/New_York For More Details: https://mskcc.cloud-cme.com/course/courseoverview?EID=55943 Description: Condensed into two comprehensive days, this accelerated course provides a high-yield review of the material tested in the American Board of Internal Medicine (ABIM) certification and recertification examinations in Medical Oncology. With the rapid expansion of knowledge in medical oncology, preparing for board exams has become increasingly challenging. This course is designed to provide a focused revie... Rockefeller Research Laboratories, 430 East 67th Street false MM/DD/YYYY


Date & Location
Friday, October 31, 2025, 7:45 AM - Saturday, November 1, 2025, 6:15 PM, Rockefeller Research Laboratories, 430 East 67th Street, New York, NY

Specialties
Specialties - Bone Marrow Transplant, Breast Medical Oncology, Gastrointestinal Oncology, Genitourinary Oncology, Head and Neck Oncology, Leukemia, Medical Oncology, Myeloma, Neuro-Oncology, Oncology and Hematology, Solid Tumor Oncology, Thoracic Medical Oncology

Overview

Condensed into two comprehensive days, this accelerated course provides a high-yield review of the material tested in the American Board of Internal Medicine (ABIM) certification and recertification examinations in Medical Oncology.

With the rapid expansion of knowledge in medical oncology, preparing for board exams has become increasingly challenging. This course is designed to provide a focused review of the diagnosis, staging, and management of solid tumors and malignant hematologic disorders. Emphasis will be placed on common, curable malignancies and other high-impact topics frequently tested on the boards.

Each topic will be delivered through concise micro-lectures, ensuring efficient coverage of essential material. Participants will also receive summary notes for each topic to support their study and exam preparation. To conclude the course, a networking reception on Saturday will offer attendees the opportunity to connect and engage with faculty and fellow participants.

This course is designed for hematology/oncology fellows preparing for initial board certification, as well as medical oncologists seeking initial certification or recertification. We're delighted to offer complimentary registration for all fellows to attend this course.

This program will be held exclusively in-person at Memorial Sloan Kettering's Rockefeller Research Laboratories.


Objectives
By attending this course, participants will be able to:

  1. Prepare for the ABIM examination in medical oncology through high yield material
  2. Highlight the latest therapeutic developments tested on the examinations
  3. Review the diagnosis, staging, and management of solid oncology and malignant hematology disorders with a focus on common and curable malignancies

Registration

Included in registration, attendees will be offered continental breakfast, lunch, and refreshment breaks. Please contact [email protected] at least one week prior to the course if you have any special dietary requests or require any specific accommodations for joining us onsite.

Discounted registration is available for specific groups. If eligible, you will receive further instructions and a promotion code to use during registration. View our Policy on Registration Discounts for more information.

Registration Rates

— Physicians (MDs, PhDs and DOs): $400
— Industry Professionals*: $700
— Fellows: Complimentary
— MSK Employees: Complimentary

For details on our cancellation terms, please review our Cancellation Policy.

*An “industry professional” is defined as any individual, regardless of their profession type (such as MDs, PhDs, APPs, RNs, etc.) that is employed by an ineligible company. View our Registration Policy for Industry Professionals for more information.


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 17.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 17.50 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.



Keywords: ABIM MOCAMA PRA Category 1In-Person


We look forward to welcoming you to Memorial Sloan Kettering Cancer Center (MSK).

If you’ll be traveling to New York City from out of town, we recommend that you plan your overnight stays as soon as possible. To make the planning a little easier, MSK has negotiated special rates and amenities at select hotels in Manhattan. Click here to view the list of select hotels and additional details on each.

For details on planning your visit to MSK, including travel and parking information, click here. Please note that parking validation is not available for attendees.

If you require any specific accommodations to attend this event in person, please contact [email protected] at least one week in advance.



MSK Course Directors 

Nicholas Mai, MD
Assistant Attending
Breast Medicine and Early Drug Development Services

Yannis K. Valtis, MD
Assistant Attending 
Leukemia and Cell Therapy Services



MSK Faculty Sponsor

Deb Schrag, MD, MPH
Chair, Department of Medicine 
George J. Bosl Chair in Medicine
View Profile

 

MSK Course Faculty 

Kathryn C. Arbour, MD
Assistant Attending
Thoracic Oncology Service 

Viswatej (Vishu) Avutu, MD
Assistant Attending
Sarcoma Medical Oncology Service 

Alexander P. Boardman, MD
Assistant Attending
Lymphoma Service 

Maria Carlo, MD
Assistant Attending
Genitourinary Oncology Service

Jamie E. Chaft, MD
Attending
Thoracic Oncology Service 

Amy M. Chan, MD, MS
Associate Attending
Brain Tumor Service 

Jie Chi, MD
Assistant Attending
Breast Medicine Service 

Samuel Cytryn, MD
Assistant Attending
Gastrointestinal Oncology Service 

Mark A. Dickson, MD
Associate Attending
Sarcoma Medical Oncology Service 

Joshua Z. Drago, MD, MS
Assistant Attending
Breast Medicine Service

Michael Foote, MD
Assistant Attending
Gastrointestinal Oncology Service 

Samuel A. Funt, MD
Assistant Attending
Genitourinary Oncology Service 

Mark B. Geyer, MD
Assistant Attending 
Leukemia and Cellular Therapy Services

Tamanna Haque, MD
Assistant Attending
Leukemia Service

Anis Hamid, MBBS, PhD
Assistant Attending
Genitourinary Oncology Service 

James J. Harding, MD
Associate Attending
Gastrointestinal Oncology Service 

Michael Hwang, MD
Assistant Attending
Thoracic Oncology Service

Gopa Iyer, MD
Associate Attending
Genitourinary Oncology Service 


Ritesh R. Kotecha, MD
Assistant Attending
Genitourinary Oncology and Cellular Therapy Services

Kristine Peregrino Lacuna, MD
Assistant Attending
Genitourinary Oncology Service 

Daniel E. Lage, MD, MBA, MSc
Assistant Attending
Genitourinary Oncology Service 


Avi Leader, MD
Assistant Attending
Hematology Service 

Jia Li, MD, PhD
Associate Attending
Gastrointestinal Oncology Service 

Ying Liu, MD, MPH
Associate Attending
Gastrointestinal Oncology Service 

Sham Mailankody, MBBS
Associate Attending
Myeloma and Cellular Therapy Services

Maliha Nusrat, MD, MS
Assistant Attending
Gastrointestinal Oncology Service 

Michael D. Offin, MD
Assistant Attending
Thoracic Oncology Service 


Mark E. Robson, MD
Chief, Breast Medicine Service

Michael Scordo, MD
Assistant Attending
Bone Marrow Transplant and Cellular Therapy Services

Sherry Shen, MD
Assistant Attending
Breast Medicine Service 

James W. Smithy, MD, MHS
Assistant Attending
Melanoma and Cellular Therapy Services

Stacy M. Stabler, MD, PhD
Associate Attending
Supportive Care Service 

Meghan C. Thompson, MD
Assistant Attending
Leukemia Service 

Rohit Thummalapalli, MD
Assistant Attending
Gastrointestinal Oncology Service 

Anna M. Varghese, MD
Associate Attending
Gastrointestinal Oncology Service 

Winston Wong, MD
Assistant Attending
Head and Neck Oncology Service 



Mitigation of Relevant Financial Relationships


Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.



Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Nick Mai, MD
MSKCC
Activity Co-Director, Conflict of Interest Peer Reviewer, Faculty
Grant or research support-Merck and Company, Inc.
Yannis Valtis, MD
MSK
Activity Co-Director, Faculty
Consulting Fee-EastRx (Relationship has ended)
Kathryn C Arbour, MD
Memorial Sloan Kettering Cancer Center
Faculty
Vishu Avutu, MD
MSK
Faculty
Alexander Paul Boardman, MD
MSK
Faculty
Consulting Fee-Bristol-Myers Squibb
Maria Carlo, MD
MSK
Faculty
Nothing to disclose
Jamie E Chaft, MD
MSK
Faculty
Amy Chan, MD
MSKCC
Faculty
Nothing to disclose
Jie Chi, MD, Assistant Attending
MSK
Faculty
Nothing to disclose
Samuel Cytryn, MD
MSKCC
Faculty
Mark Dickson, MD
MSK
Faculty
Joshua Drago, MD
MSK
Faculty
Advisor-AstraZeneca|Consulting Fee-Revelio Therapeutics (Relationship has ended)|Consulting Fee-Intellisphere LLC (Relationship has ended)|Consulting Fee-Biotheranostics (Relationship has ended)|Consulting Fee-Genagon (Relationship has ended)|Consulting Fee-AmMax Bio (Relationship has ended)|Consulting Fee-NuProbe
Michael Foote, MD
MSK
Usa
Faculty
Samuel A. Funt, MD
MSK
Faculty
Consulting Fee-Merck and Company, Inc.|Grant or research support-ALX Oncology|Consulting Fee-Generate:Biomedicines|Grant or research support-Decibel (Relationship has ended)|Grant or research support-AstraZeneca|Grant or research support-Genentech, Inc.|Stocks or stock options, excluding diversified mutual funds-Allogene Therapeutics |Stocks or stock options, excluding diversified mutual funds-Urogen|Stocks or stock options, excluding diversified mutual funds-Kronos Bio|Stocks or stock options, excluding diversified mutual funds-Neogene Therapeutics (Relationship has ended)
Mark B Geyer , MD
MSK
Faculty
Advisor-Sanofi-Aventis|Grant or research support-Amgen|Grant or research support-Actinium Pharmaceuticals, Inc|Advisor-Takeda Pharmaceuticals, Inc. (Relationship has ended)|Grant or research support-Tigen
Anis Hamid
MSKCC
Faculty
Tamanna Haque, MD
MSKCC
Faculty
Advisor-Servier (Relationship has ended)|Advisor-Morphosys (Relationship has ended)|Advisor-Bristol-Myers Squibb (Relationship has ended)
James J Harding, MD
MSK
Faculty
Advisor-Bristol-Myers Squibb|Advisor-Eli Lilly and Company (Relationship has ended)|Advisor-Merck and Company, Inc. (Relationship has ended)|Advisor-Adaptiimune (Relationship has ended)|Advisor-CytomX (Relationship has ended)|Advisor-Eisai, Inc. (Relationship has ended)|Advisor-Exelexis (Relationship has ended)|Advisor-Hepion (Relationship has ended)|Advisor-Medivir (Relationship has ended)|Advisor-QED (Relationship has ended)|Advisor-Zymeworks|Grant or research support-Bristol-Myers Squibb
Michael Hwang, MD
MSKCC
Faculty
Nothing to disclose
Gopakumar Iyer, MD
MSK
Faculty
Advisor-Flare Therapeutics|Advisor-Biohaven Pharmaceuticals (Relationship has ended)|Grant or research support-AstraZeneca|Grant or research support-Pfizer, Inc.|Consulting Fee-EMD Serono (Relationship has ended)|Advisor-LOXO Oncology|Honoraria-DAVA Oncology (Relationship has ended)|Advisor-Aadi Biosciences
Ritesh Kotecha, MD
MSK
Faculty
Grant or research support-Pfizer (Relationship has ended)|Grant or research support-Exelixis|Grant or research support-Novartis|Grant or research support-Takeda (Relationship has ended)|Grant or research support-ArsenalBio|Grant or research support-Allogene Therapeutics|Grant or research support-Xencor|Advisor-Eisai (Relationship has ended)
Kristine Lacuna, MD
MSKCC
Faculty
Daniel Lage, MD, MBA
MSK
Faculty
Consulting Fee-Bristol-Myers Squibb (Relationship has ended)
Avi Leader, MD
MSK
Faculty
Honoraria-Leo Pharma (Relationship has ended)
Jia Li, MD, PhD
MSK
Faculty
Nothing to disclose
Ying Liu, MD, MPH
MSK
Faculty
Grant or research support-AstraZeneca|Grant or research support-GlaxoSmithKline|Grant or research support-Repare Therapeutics (Relationship has ended)|Advisor-Myriad Genetics
Sham Mailankody, MD
MSK
Usa
Faculty
Grant or research support-Johnson and Johnson|Grant or research support-Bristol-Myers Squibb|Grant or research support-Takeda Pharmaceuticals, Inc. (Relationship has ended)|Grant or research support-Allogene Therapeutics|Grant or research support-Fate Therapeutics|Consulting Fee-Johnson and Johnson (Relationship has ended)|Review Panel Member-Abbvie|Consulting Fee-Legend Biotech (Relationship has ended)|Advisor-Optum|Consulting Fee-Evicore (Relationship has ended)|Honoraria-MJH life Sciences (Relationship has ended)|Honoraria-Physician Education Resource (Relationship has ended)|Consulting Fee-Bristol-Myers Squibb (Relationship has ended)|Review Panel Member-ArcellX|Consulting Fee-Galapagos Therapeutics (Relationship has ended)|Grant or research support-Caribou Therapeutics
Maliha Nusrat, MBBS
Memorial Sloan Kettering Cancer Center
Faculty
Michael Offin, MD
MSK
Faculty
Advisor-Mesothelioma Applied Research Foundation|Honoraria-Jazz Pharmaceuticals (Relationship has ended)|Honoraria-ASTRO (Relationship has ended)|Honoraria-OncLive (Relationship has ended)|Honoraria-Targeted Oncology (Relationship has ended)|Grant or research support-Mesothelioma Applied Research Foundation|Grant or research support-LUNGevity|Grant or research support-Department of Defense
Mark Robson, MD
MSK
Faculty
Michael Scordo, MD
MSK
Faculty
Consulting Fee-Omeros Corporation (Relationship has ended)|Grant or research support-Omeros Corporation (Relationship has ended)|Grant or research support-Amgen, Inc. (Relationship has ended)|Consulting Fee-Kite - A Gilead Company (Relationship has ended)|Grant or research support-Angiocrine Bioscience, Inc.|Consulting Fee-Angiocrine Bioscience, Inc. (Relationship has ended)|Grant or research support-Sanofi-Aventis|Grant or research support-Bristol-Myers Squibb (Relationship has ended)|Advisor-Miltenyi Biotec (Relationship has ended)
Sherry Shen, MD
MSK
Faculty
Honoraria-MJH Life Sciences (Relationship has ended)|Grant or research support-Merck and Company, Inc.|Grant or research support-Sermonix Pharmaceuticals|Consulting Fee-AstraZeneca
James Smithy, MD
MSK
Usa
Faculty
Stacy Stabler, MD, PhD
MSK
Faculty
Nothing to disclose
Meghan C Thompson, MD
MSK
Faculty
Paid consultant-Beigene|Grant or research support-Beigene|Grant or research support-Genmab|Grant or research support-Abbvie|Grant or research support-Adaptive|Grant or research support-AstraZeneca|Grant or research support-Genentech, Inc.|Grant or research support-Genmab (Relationship has ended)|Grant or research support-Nurix Therapeutics (Relationship has ended)|Paid consultant-Janssen|Paid consultant-Loxo Oncology at Lilly (Relationship has ended)|Other: Payment for travel and lodging, honoraria-Dava Oncology (Relationship has ended)|Paid consultant-AstraZeneca (Relationship has ended)|Paid consultant-Abbvie (Relationship has ended)
Rohit Thummalapalli, MD
MSKCC
Faculty
Nothing to disclose
Anna Mary Varghese, MD
MSK
Faculty
Nothing to disclose
Winston Wong, MD
MSK
Faculty
Deb Schrag, MD, MPH
MSK
Faculty, Physician Faculty Sponsor
Consulting Fee-SWISS Re (Relationship has ended)|Advisor-Genentech, Inc.


CME Courses

Live Courses
On Demand eLearning
Coming Soon

Resources & Policies

CME Program Terms of Use
Registration Discounts
Cancellation Policy
Industry Professionals

Attendee & Faculty Information

My CME / Attendee Resources
Claim RSS Credit (MSK Staff)
Faculty Disclosure Form
Faculty Tasks Page

Connect

Locations & Visitor Info
Help / Contact Us
Subscribe to CME Announcements




MSK CME

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

©2025 Memorial Sloan Kettering Cancer Center